Oncology Institute (TOIIW) Return on Invested Capital (2021 - 2026)

Oncology Institute (TOIIW) has 6 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed N/A YoY), and the FY2025 full-year result was 0.0%, changed N/A from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q4 2022 and bottomed at 0.01% in Q2 2025.
• The 5-year median for Return on Invested Capital is 0.01% (2026), against an average of 0.0%.
• The widest annual swing landed in 2022, when Return on Invested Capital gained 1 bps; it then slipped 1 bps in 2023.
• A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then tumbled by 177 bps to 0.01% in 2023, then retreated by 9 bps to 0.01% in 2024, then dropped by 3 bps to 0.01% in 2025, then gained by 8 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.

Peer Comparison